Half-year report · Q2
7915.TEDINET S100WGWC
Period2025-01-01 → 2025-06-30
Filed2025-08-07
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 40
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | ¥2.7bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥4.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥6.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥6.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥129m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.9bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥4.3bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥361m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.3bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥239.7bn | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥251.9bn | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥259.2bn | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥128.6bn | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥136.7bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥111.1bn | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥115.2bn | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥121.8bn | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥108.8bn | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥114.0bn | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥120.6bn | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥37.8bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥51.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥44.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥3.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥12.3bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥10.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥9.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥11.4bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥13.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥3.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥9.1bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥5.8bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥2.72 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥80.31 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥88.04 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 45.4% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 46.5% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 14
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥365m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.2bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥4.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥420m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥915m |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥2.7bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.0bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥5.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 855
| Item | Context | Value | Unit |
|---|---|---|---|
| Intersegment sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 495000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 556000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -556000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration | － | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 37622000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 29761000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 23459000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReportableSegmentsMember | 90843000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6762000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 97605000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -556000000 | JPY |
| Net sales IFRS | CurrentYTDDuration | 97049000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 2169000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 1097000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 1267000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 4534000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 365000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4899000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -2205000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 2693000000 | JPY |
| Finance income IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration | 296000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Finance costs IFRS | CurrentYTDDuration | 1771000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 1218000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-08-07 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第107期中(自 2025年1月1日 至 2025年6月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)NISSHA株式会社 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |